Eli Lilly reports 4Q loss on ImClone costs (AP)

AP – Drugmaker Eli Lilly & Co. said Thursday it swung to a fourth-quarter loss on charges from buying cancer-drug maker ImClone Systems Inc.

Leave a Reply